No | Themes | Sub-Themes | Key Findings | Type of Health Facility | |
---|---|---|---|---|---|
Health Center | Level 1 Hospital | ||||
1 | Health System Level Experiences | a) Rapid scale-up of 6 multi-month dispensing (6MMD) | Consistent and longer drug refill was appreciated by clients | XX | XX |
Reduced clients’ waiting time due to decongestion of health facility | XX | XX | |||
b) Provision of high-quality health care services by health care workers | Clients appreciated good attitude of health care workers | XX | XX | ||
Clients appreciated good communication of health care workers | X | ||||
c) Complaints about service delivery | Bad attitude of health care workers | X | |||
Reduced one-on-one interaction | X* | ||||
d) Introduction of COVID-19 measures | General appreciation of COVID-19 prevention measures | XX | XX | ||
Perception of COVID-19 measures as barrier to care | X | ||||
e) Concerns | Fear of contracting COVID-19 infection | XX | XX | ||
Uncertainty about mechanism and timing of receipt of cluster of differentiation 4 (CD4) and viral load (VL) results | XX | XX | |||
Fear of HIV status disclosure/Stigma | X | ||||
2 | Household Level Experiences | a) Financial impacts | Loss of income | XX | XX |
Loss of employment | XX | XX | |||
Food insecurity | XX | XX | |||
b) Non-financial impacts | Disruptions in social interactions due to COVID-19 restrictions on movement and gatherings | XX | XX | ||
3 | Individual Level Experiences | a) Healthy behaviours | Motivation to stay healthy | XX | XX |
Motivation to religiously take ART medication | X | ||||
b) Unhealthy behaviours | Discouragement to take ART medication due to side effects and food insecurity | X | |||
c) Laboratory Monitoring | Increased value for CD 4 and VL monitoring | XX | XX |